GlassScriptPhysician profile
Monilla M Dent
NPI 1851554968
$2,671.92
in general payments reported to CMS, 2019-2025
30 companies · $605 in 2025
The $605 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $552 · 2020: $105 · 2021: $90.83 · 2022: $12.59 · 2023: $940 · 2024: $366 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,760 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,760.43 |
| Education | $150.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $633.11 | 2019-2024 | Veozah |
| Shield Therapeutics INC | $199.50 | 2023-2025 | Accrufer |
| Biogen, INC. | $193.42 | 2025 | Zurzuvae |
| Organon LLC | $173.02 | 2022-2025 | Nexplanon |
| Pfizer INC. | $144.76 | 2019-2025 | |
| Cytyc Surgical Products, LLC | $144.12 | 2023 | Acessa Provu System |
| Bayer Healthcare Pharmaceuticals INC. | $126.52 | 2019-2025 | |
| Medtronic, INC. | $114.83 | 2023 | Ligasure |
| Exeltis, USA INC. | $104.73 | 2020-2025 | Slynd |
| Sumitomo Pharma America, INC. | $97.60 | 2023-2025 | Myfembree |
| Abbvie INC. | $93.94 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $73.89 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $66.93 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Coopersurgical, INC. | $55.94 | 2019-2025 | Paragard T 380a, Advincula Delineator Uterine Manipulator, Ally II Ups |
| Millicent US INC | $52.99 | 2024-2025 | Intrarosa, Femring, Femlyv |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $50.29 | 2023 | Gelpoint V-Path |
| Minerva Surgical, INC | $48.87 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $47.76 | 2019 | |
| Mayne Pharma Commercial LLC | $44.47 | 2025 | |
| Allergan, INC. | $39.33 | 2019 | |
| Mylan Pharmaceuticals INC. | $21.44 | 2019 | |
| Daiichi Sankyo INC. | $19.91 | 2024 | Injectafer |
| Meditrina | $17.70 | 2023-2024 | |
| Hologic Sales and Service, LLC | $17.30 | 2024 | Aptima |
| Exact Sciences Corporation | $16.68 | 2024 | Cologuard Collection Kit |
| Vertical Pharmaceuticals, LLC | $16.26 | 2019 | |
| Provepharm INC. | $15.84 | 2025 | Bludigo |
| Duchesnay USA Incorporated | $14.90 | 2019 | |
| Amgen INC. | $14.10 | 2025 | Prolia, Evenity |
| Therapeuticsmd, INC. | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monilla Dent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.